Search
for

    Research

    5 / 1000+ results
      Hirsutism

      research Hirsutism

      37 citations , December 2007 in “International journal of clinical practice”
      This review discusses the definition, pathogenesis, diagnosis, and management of hirsutism and reports no new clinical results.
      Update on Idiopathic Hirsutism: Diagnosis and Treatment

      research UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT

      6 citations , July 2013 in “Acta Clinica Belgica”
      This review discusses idiopathic hirsutism and suggests that combination treatment, including androgen suppression and cosmetic methods, is most effective, but notes that its pathogenesis remains unclear.
      Hirsutism

      research Hirsutism

      12 citations , May 2005 in “Current obstetrics and gynaecology/Current obstetrics & gynaecology”
      This review discusses the causes and treatment strategies for hirsutism, emphasizing that combination therapy targeting androgen suppression and hair removal techniques is most effective; no new clinical results are reported.
      Is Dehydroepiandrosterone a Hormone?

      research Is dehydroepiandrosterone a hormone?

      403 citations , November 2005 in “Journal of Endocrinology”
      This review discusses the role of DHEA in intracrinology, highlighting its impact on breast and prostate cancer treatment and potential as a menopause therapy, but reports no new research findings.

    Community Join

    4 / 1000+ results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

       133 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community Having androgen receptor density and sensitivity at wrong f*ing place

      in Satire  7 upvotes 1 year ago
      The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.

    Learn

    5 / 801 results

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Fluridil

      a topical anti-androgen with less systemic involvement